跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55,457 条关于
“CD19 t-haNK cells”
全部
55,457
临床试验
38,258
药物
5,890
机构
191
资讯
11,118
去年
ImmunityBio Initiates Phase I Trial of CD19-Targeted haNK Cell Therapy for NHL in South Africa
去年
ImmunityBio Initiates Phase 1 Trial of CD19 t-haNK Cell Therapy for Non-Hodgkin Lymphoma
去年
ImmunityBio Launches Phase 1 Trial of CD19 t-haNK Cell Therapy for Non-Hodgkin Lymphoma
去年
ImmunityBio Doses First Patients in Phase 1 CAR-NK Cell Therapy Trial for Non-Hodgkin's Lymphoma
去年
FDA Approves Autolus' Aucatzyl, a CD19 CAR T-cell Therapy for B-cell ALL
去年
CD19 CAR-T Cell Therapy Shows Promise in Relapsed t(8;21) AML Despite Short-Term Remission
5年前
Bispecific CAR-T Therapy Targeting CD19/CD20 Shows Promise in Relapsed B-Cell Lymphoma
3个月前
Dual-Target CD19/BCMA CAR T-Cell Therapy Demonstrates Profound Remission in Refractory Systemic Sclerosis
11个月前
CD19 CAR T-Cell Therapy Demonstrates Promising Activity in Richter Transformation Despite Modest Outcomes
去年
Cullinan Therapeutics Advances Novel CD19 T Cell Engager for Autoimmune Disease Treatment
第 1 页,共 1112 页
上一页
下一页